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Summary  In  this  study,  we  aimed  to  evaluate  the  incidence  and  economic  burden
of  prosthetic  joint  infections  (PJIs)  in  a  university  hospital  in  a middle-income  coun-
try.  Surveillance  data  between  April  2011  and  April  2013  in  the  Orthopedic  Surgery
Department  was  evaluated.  Patients  (>16  years  old)  who  had  primary  arthroplasty
in  Erciyes  University  were  included  in  the  study,  and  patients  with  preoperative
infection  were  excluded.  Patients  were  followed  up  during  their  stay  in  the  hospital
and  during  readmission  to  the  hospital  for  PJI  by  a  trained  Infection  Control  Nurse.
During  the  study  period,  670  patients  were  followed  up.  There  were  420  patients
(62.7%)  with  total  hip  arthroplasty  (THA),  241  (36.0%)  with  total  knee  arthroplasty
(TKA)  and  9  (1.3%)  with  shoulder  arthroplasty  (SA).  The  median  age  was  64,  and
70.6%  were  female.  The  incidence  of  PJI  was  1.2%  (5/420)  in  THA,  4.6%  (11/241)  in
TKA  and  0%  (0/9)  in  SA.  PJI  was  signiﬁcantly  more  prevalent  in  TKA  (p  =  0.029).  All
of  the  PJIs  showed  early  infection,  and  the  median  time  for  the  development  of  PJI
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was  23.5  days  (range  7—120  days).  The  median  total  length  of  the  hospital  stay  was
seven  times  higher  in  PJI  patients  than  patients  without  PJI  (49  vs.  7  days,  p  =  0.001,
retrospectively).  All  hospital  costs  were  2-  to  24-fold  higher  in  patients  with  PJI  than  in
those  without  PJI  (p  =  0.001).  In  conclusion,  the  incidence  and  economic  burden  of  PJI
was  high.  Implementing  a  national  surveillance  system  and  infection  control  protocols
in  hospitals  is  essential  for  the  prevention  of  PJI  and  a  cost-effective  solution  for  the
-middle-income  countries.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
ed.
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recommended  infection  control  measures  (preop-
erative  blood  sugar  regulation,  hair  removal,  hairhealthcare  system  in  low
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rosthetic  joint  infection  (PJI)  is one  of  the  most
evere complications  after  arthroplasty  that  affects
he quality  of  a  patient’s  life  [1,2].  The  incidence
f PJI  is  between  1%  and  2%  for  primary  hip  and
nee arthroplasties,  respectively.  The  incidence  of
nfection following  a  revision  hip  and  arthroplasty
as been  reported  approximately  2%—6%  [3]. Fur-
hermore,  the  dimension  of  the  problem  is  huge  in
ow-middle-income  countries  because  of  their  own
roblems in  their  hospitals  [4].  The  management
f PJI  almost  always  requires  surgical  intervention
nd extended  courses  of  antimicrobial  therapy  that
laces a  signiﬁcant  economic  burden  on  healthcare
ystem. The  economic  burden  of  PJI  is  relatively
ell known  in  industrialized  countries  [1,2]. How-
ver, there  is  limited  data  about  the  extent  of  the
roblem  and  economic  burden  of  PJIs  on  the  health-
are system  in  developing  countries.
The aim  of  this  study  was  to  evaluate  the  inci-
ence and  economic  burden  of  PJIs  in  a  university
ospital in  Turkey.
atients and methods
urkey  is  a  middle-income  country  according  to  the
orld Bank  classiﬁcation  of  2014  [5].  This  study
as conducted  at  Erciyes  University,  a  referral-
ased tertiary  hospital  in  the  Central  Anatolian
egion of  Turkey  with  1300  beds.  There  are  9  sur-
eons in  the  Orthopedic  Surgery  Department  and
ver 600  arthroplasties  are  performed  per  year.  The
esign of  the  operating  theater  is not  optimal  [6],
nd there  is  no  ventilation  system  or  trafﬁc  con-
rol in  the  orthopedic  operating  room.  Prospective,
ctive surveillance  of  prosthetic  joint  infection  has
een performed  since  2007,  and  feedback  is  pro-
ided  annually  to  orthopedics  with  infection  control
easures.  All  surveillance  data  were  collected  as
r
p
r quality  and  safety  measure  for  the  hospital,
nd institutional  approval  was  given  to  report  the
ata.
In this  study,  the  surveillance  data  collected
etween April  2011  and  April  2013  in  the  Ortho-
edic Surgery  Department  was  evaluated.  Patients
>16 years  old)  who  had  primary  arthroplasty  in
rciyes University  were  included  in  the  study,
nd patients  with  preoperative  infection  were
xcluded.  Patients  were  followed  up  during  their
tay in  the  hospital  and  during  readmission  to
he hospital  for  PJI  by  a trained  Infection  Con-
rol Nurse  for  two  years.  PJI  was  deﬁned  according
o the  Center  for  Disease  Control  and  Prevention
CDC) deﬁnitions  that  include  laboratory  and  clin-
cal criteria.  At  least  one  of  the  following  criteria
as required:  (1)  two  positive  periprosthetic  (tis-
ue or  ﬂuid)  cultures  with  identical  organisms;
2) a sinus  tract  communicating  with  the  joint;
nd (3)  having  three  of  the  following  minor  crite-
ia: (a)  elevated  serum  C-reactive  protein  (CRP;
100 mg/L)  and  erythrocyte  sedimentation  rate
ESR; >30  mm/h);  (b)  elevated  synovial  ﬂuid  white
lood cell  (WBC;  >10,000  cells/L)  count;  (c)  ele-
ated synovial  ﬂuid  polymorphonuclear  neutrophil
ercentage (PMN%  >90%);  (d)  positive  histological
nalysis of  periprosthetic  tissue  (>5  neutrophils
PMNs) per  high  power  ﬁeld-400×);  and  (e)  a
ingle positive  periprosthetic  (tissue  or  ﬂuid)  cul-
ure [7]. The  infections  were  described  as  early
within 3 months)  and  delayed  (between  3  months
nd 2  years).  Multi-drug  resistance  (MDR)  was
eﬁned as  diminished  susceptibility  to  2  or  more
ntibiotic  classes  [8].  Demographic  characteristics
nd adherences  to  basic,  modiﬁable  and  stronglyemoval time,  chlorhexidine  bathing,  antimicrobial
rophylaxis-AMP)  were  observed  [9]. The  billing
ecords  for  each  patient  with  PJI  and  without
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PJI  were  calculated.  Data  on  costs  were  obtained
using the  hospital’s  accounting  system.  In  calcu-
lating the  costs  of  PJI,  the  cost  of  antibiotics,
laboratory,  radiology,  prosthesis,  operation,  total
bed stay  and  other  costs  (other  drugs,  intravenous
infusions, etc.)  were  considered.  Unfortunately,
the costs  associated  with  the  surgeon’s  service,
the service  of  other  physicians  (anesthesiologist,
infection  specialist,  etc.)  and  hospital  staff  (nurses,
physiotherapist,  caregivers,  etc.)  or  subsequent
expenses in  physical  therapy  could  not  be  measured
and included  in  this  analysis.  The  costs  were  calcu-
lated in  United  States  (US)  dollars  based  on  the  2013
exchange  rate  in  Turkey.
Statistical  analysis
The  Mann—Whitney  U  test  was  used  for  continuous
variables and  Fisher’s  exact  test  and  the  chi-
squared  test  were  used  for  categorical  variables.
Differences were  considered  statistically  signiﬁcant
at p  < 0.05.
u
A
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Table  1  Demographic  characteristics  and  infection  contro
PJI  
n  =  
Median  age  (range)  65  (
Female  gender  11  
Operation
Total  hip  prosthesis  5  
Total  knee  prosthesis  11  
Shoulder  prosthesis  0  
Type  of  operation
Urgent  operations  0  
Elective  operations  16  
Underlying  disease 8 
Anemia  4  
Hypoalbuminemia  (n  =  567)  1/1
Cigarette  0  
Infection  control  measures
Preoperative  blood  sugar  regulation  (n  =  130) 3/3
Hair  removal  2  
Hair  removal  method
Razor  0  
Clipper  2  
Hair  removal  time
At  operation  1  
Operation  day  1  
≥1  day  0  
Chlorhexidine  bathing  (n  =  300)  3/9
Antimicrobial  prophylaxis
Appropriate  antibiotic  4  
Appropriate  timing  16  
Appropriate  duration  2  
Preoperative  hospital  stay  median  (range)  2  (1
Total  hospital  stay  median  (range)  49  (E.  Alp  et  al.
esults
uring  the  study  period,  670  patients  were  fol-
owed  up.  There  were  420  (62.7%)  patients  with
otal hip  arthroplasty  (THA),  241  (36.0%)  with  total
nee arthroplasty  (TKA)  and  9  (1.3%)  with  shoul-
er arthroplasty  (SA).  The  median  age  was  64
nd 70.6%  were  female.  The  incidence  of  PJI  was
.2%  (5/420)  in  THA,  4.6%  (11/241)  in  TKA  and
% (0/9)  in  SA.  PJI  was  signiﬁcantly  more  preva-
ent in  TKA  (p  = 0.029);  however,  other  demographic
haracteristics  of  patients  and  infection  control
easures were  not  signiﬁcantly  different  between
atients with  and  without  PJI.  AMP  was  used  in
ll patients;  however,  broad  spectrum  AMP  [ampi-
illin/sulbactam  —  552  (82.4%)  patients,  cefazolin
lus gentamicin  —  34  (5.1%)  patients,  cefazolin  plus
iproﬂoxacin  — 2  (0.3%),  tigecycline  —  1  (0.2%)]  was
sed in  589  (88%)  of  patients  and  the  duration  of
MP was  >24  h in  643  (96%)  of  patients  (Table  1).
icroorganisms  were  isolated  in  six  patients  and
l  measures  of  patients  with  and  without  PJI.
Without  PJI  p
16  %  n  =  654  %
40—85)  64  (16—98)  0.823
68.8  462  70.6  0.870
31.3  415  63.5
0.02968.8  230  35.2
0.0  9  1.4
0.0  14  2.1  1.000
100  640  97.9
50.0  364  55.7  0.800
25  174  25  1.000
6  6.3  115/551  20.9  0.214
0.0  32  4.9  0.628
 —  101/127  79.5  0.611
12.5  112  17.1  0.753
0.0  3  2.7  1.000
—  109  97.3
50  22  19.6
0.70450  52  46.4
0  38  33.9
 33.3  111/291  38.1  1.000
25  77  11.8  0.116
100  650  99.4  1.000
12.5  25  3.8  0.133
—12)  1  (0—12)  0.227
16—108)  7  (2—77)  0.001
Prosthesis  infection  
Table  2  Hospital  costs  of  various  positions  with  and
without  PJI  patients.
Cost  per
patient  ($)
With  PJI
(median)
Without  PJI
(median)
p
Antibiotics  1373  57  0.001
Laboratory  574  117.5  0.001
Radiology  80  29.5  0.001
Prosthesis 3872  2034  0.002
Operation  892  330  0.001
Bed  stay 872  141.5 0.001
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sOther  9337  3226  0.001
Total  16.999  5.937  0.001
hey  were  all  multidrug-resistant  gram  negatives
Acinetobacter baumannii-2-, Escherichia  coli-3-,
lebsiella  pneumonia-1-).  All  the  PJIs  were  early
nfections,  and  the  median  time  for  the  develop-
ent of  PJI  was  23.5  days  (range  7—120  days).
he median  total  length  of  hospital  stay  was  seven
imes  higher  in  PJI  patients  than  patients  without
JI (49  vs.7  days,  p  = 0.001,  retrospectively).  Nine
atients  had  polietilen  insert  changes,  debride-
ent and  antimicrobial  therapy,  two  patients  had
ne-stage  revision  and  ﬁve  patients  had  two-stage
evision. Hospital  costs  were  2-  to  24-fold  higher
n patients  with  PJI  relative  to  those  without  PJI
p =  0.001)  (Table  2).
iscussion
JI  is  a  serious  and  feared  complication  of  arthro-
lasty, and  in  this  study,  the  incidence  of  PJI  in  TKA
4.6%)  was  higher  than  previously  reported  in  the
iterature  [10].  Additionally,  this  rate  is higher  than
hose in  national  surveillance  reports.  The  mean  PJI
ate after  TKA  was  reported  to  be  between  0.7  and
.7 in  2013  in  a  Turkish  national  surveillance  report
http://www.saglik.gov.tr/DH/dosya/1-88693/h/
hesa-analiz-2013.pdf).  This  high  rate  may  be
ue to  our  hospital  infrastructure  and  a  lack  of
dherence  to  infection  control  measures  in  surgical
nits. Additionally,  a  number  of  risk  factors  for  PJI,
uch as  obesity,  diabetes  mellitus,  immunosuppres-
ion, environmental  factors  in  the  operating  room,
tc. have  been  identiﬁed  [10,11].  In  this  study,
he demographic  characteristics  of  patients  and
nfection  control  measures  were  not  signiﬁcantly
ifferent between  patients  with  and  without  PJI.
nfortunately,  operative  techniques  and  infection
ontrol  in  the  operative  and  postoperative  phase
ere not  observed  in  this  study.  However,  all  thenfections  were  early  infections,  which  is  indicative
f the  contamination  of  the  wound  during  surgery
nd usually  appears  from  the  moment  that  the
peration  is  performed  up  to  three  months  later,
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epending  on  the  microorganism  responsible  for
he infection.
In addition  to  the  psychosocial  consequences,
he economic  impact  on  both  the  hospital  and
ealth care  system  should  not  be  ignored.  The  cost
f a  cure  for  this  type  of  nosocomial  infection  is
elatively  well  known  in  industrialized  countries
$30,000—70,000  per  patient)  [1,2];  however,  it  is
 mystery  in  developing  countries  because  of  insuf-
cient data.  To  the  best  of  our  knowledge,  this
eport  is  the  ﬁrst  from  a middle-income  country
n the  economic  impact  of  PJIs  on  healthcare  sys-
em. All  hospital  costs  were  signiﬁcantly  higher  in
atients with  PJI,  and  the  total  hospital  cost  was  2.8
imes higher  ($16,999  versus  $5937)  in  patients  with
JI than  those  without  PJI.  Isolated  microorgan-
sms were  all  MDR  pathogens,  and  the  management
f these  microorganisms  carries  a  higher  ﬁnancial
urden [12].
Resistance  and  its  spread  among  bacteria  is  gen-
rally the  result  of  selective  antibiotic  pressure.
he inappropriate  and  uncontrolled  use  of  antimi-
robial  agents  contributes  to  the  selection  of  MDR
athogens.  Additionally,  in  this  study,  most  patients
eceived broad  spectrum  AMP  (88%)  for  a longer
eriod that  probably  promoted  the  MDR  etiology
n PJIs.  In  developing  countries,  many  surgeons,
n an  attempt  to  reduce  the  SSI  rate,  adopt  this
MP policy  because  of  the  lack  of  optimal  envi-
onmental  conditions  in  their  hospitals.  However,
MP is  not  a substitute  for  the  appropriate  asep-
ic surgical  practice  and  other  infection  control
easures.
Our study  had  several  limitations.  First,  this
as a retrospective  study  from  surveillance  data;
herefore,  collection  bias  may  have  occurred.  How-
ver, our  results  showed  no  signiﬁcant  differences
n the  basic  demographic  characteristics  between
atients  with  and  without  PJI.  Second,  data  on
osts were  obtained  using  the  hospital’s  account-
ng system;  therefore,  we  could  not  obtain  and
ifferentiate  (i.e.,  other  costs)  all  the  cost  data
or economic  analyses.  Third,  operative  techniques
nd infection  control  in  the  operative  and  post-
perative  phase  were  not  observed  in  this  study;
onsequently,  deﬁnite  recommendations  could  not
e made  based  on  these  results.
In conclusion,  this  study  shows  that  PJI  is  still
he most  signiﬁcant  complication  in  orthopedic
urgery, and  the  economic  impact  of  nosocomial
nfections continues  to  be  considerable  in  a univer-
ity hospital.  Implementing  a  national  surveillance
ystem and  infection  control  protocols  in  hospi-
als is  essential  for  the  prevention  of  PJI  and  is
 cost-effective  solution  for  healthcare  systems  in
ow-middle-income  countries.
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